Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes.
Saved in:
| Title: | Human responses to the DNA prime/chimpanzee adenovirus (ChAd63) boost vaccine identify CSP, AMA1 and TRAP MHC Class I-restricted epitopes. |
|---|---|
| Authors: | Ganeshan H; Naval Medical Research Command, Silver Spring, Maryland, United States of America.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, United States of America., Huang J; Naval Medical Research Command, Silver Spring, Maryland, United States of America.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, United States of America., Belmonte M; Naval Medical Research Command, Silver Spring, Maryland, United States of America.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, United States of America., Belmonte A; Naval Medical Research Command, Silver Spring, Maryland, United States of America.; General Dynamics Information Technology, Falls Church, Virginia, United States of America., Inoue S; Naval Medical Research Command, Silver Spring, Maryland, United States of America.; General Dynamics Information Technology, Falls Church, Virginia, United States of America., Velasco R; Naval Medical Research Command, Silver Spring, Maryland, United States of America.; General Dynamics Information Technology, Falls Church, Virginia, United States of America., Maiolatesi S; Naval Medical Research Command, Silver Spring, Maryland, United States of America.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, United States of America., Limbach K; Naval Medical Research Command, Silver Spring, Maryland, United States of America.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, United States of America., Patterson N; Naval Medical Research Command, Silver Spring, Maryland, United States of America.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, United States of America., Sklar MJ; Naval Medical Research Command, Silver Spring, Maryland, United States of America., Soisson L; United States Agency for International Development (USAID), Washington, DC, United States of America., Epstein JE; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Edgel KA; Naval Medical Research Command, Silver Spring, Maryland, United States of America., Peters B; La Jolla Institute of Allergy and Immunology, La Jolla, California, United States of America., Hollingdale MR; Naval Medical Research Command, Silver Spring, Maryland, United States of America.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland, United States of America., Villasante E; Naval Medical Research Command, Silver Spring, Maryland, United States of America., Duplessis CA; Naval Medical Research Command, Silver Spring, Maryland, United States of America., Sedegah M; Naval Medical Research Command, Silver Spring, Maryland, United States of America. |
| Source: | PloS one [PLoS One] 2025 Feb 13; Vol. 20 (2), pp. e0318098. Date of Electronic Publication: 2025 Feb 13 (Print Publication: 2025). |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
